Author:
Chi Xiaoling,Xiao Huanming,Shi Meijie,Cai Gaoshu,Xie Yubao,Jiang Junmin,Tian Guangjun,Wu Shuduo,Zhang Chaozhen,Zhao Pengtao,Chen Jiezhen
Funder
the National Major Projects of Science and Technology, China
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,General Medicine
Reference18 articles.
1. Xu Y, Zhang YG, Wang X, Qi WQ, Qin SY, Liu ZH, Jiao J, Wang JB. Long-term antiviral efficacy of entecavir and liver histology improvement in Chinese patients with hepatitis B virus-related cirrhosis. World J Gastroenterol. 2015;21(25):7869–76.
2. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH, Grp R-HS. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. Jama-J Am Med Assoc. 2006;295(1):65–73.
3. European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol. 2012;57(1):167–85.
4. Chinese Society of Hepatology and Chinese Society of Infectious Diseases C, association M. the guideline of prevention and treatment for chronic hepatitis B (2010 version). Chin J Hepatol. 2011;19(1):13–24.
5. Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH. AASLD guidelines for the treatment of chronic hepatitis B. Hepatology. 2016;63(1):261–83.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献